Watch MDNC. Know when insiders buy.
One email the day a filing lands. Free.
MDNC
Medinotec Inc.
5.00
+0.00 +0.00%
USD · close Nov 3
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
—
not graded: no insider, short or call data yet
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $58.8MP/E 62.5DIV YIELD —FCF YIELD —REV TTM $10.2M +2.2%NET INCOME $903K −58.7%NET CASH —52W 5.00 – 5.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2027 · May 31 | $2.7M | +24.2% | 49.3% | $181K | $222K | +95.1% | 0.02 | −$176K | $40K | −$216K | Jul 9 |
| Q4 2026 · Feb 28derived | $1.8M | −48.3% | 46.9% | −$264K | −$69K | −104.7% | 0.00 | −$121K | — | — | May 28 |
| Q3 2026 · Nov 30 | $2.5M | −1.1% | 53.1% | $553K | $403K | +30.0% | 0.03 | $563K | — | — | Jul 9 |
| Q2 2026 · Aug 31 | $3.2M | +79.4% | 61.9% | $529K | $347K | +21.7% | 0.03 | $1.2M | — | — | Oct 8 |
| Q1 2026 · May 31 | $2.1M | +70.5% | 42.8% | $277K | $114K | +30.5% | 0.01 | −$759K | — | — | Jul 9 |
| Q4 2025 · Feb 28derived | $3.5M | +56.6% | 66.5% | $2M | $1.5M | +1398.8% | 0.12 | $99K | −$1K | $100K | May 28 |
| Q3 2025 · Nov 30 | $2.6M | +28.1% | 40.6% | $527K | $310K | — | 0.03 | $125K | $73K | $52K | Jul 9 |
| Q2 2025 · Aug 31 | $1.8M | +414.3% | 46.2% | $436K | $285K | — | 0.02 | $408K | $24K | $385K | Oct 8 |
| Q1 2025 · May 31 | $1.3M | — | 48.0% | $269K | $87K | — | 0.01 | $246K | −$6K | $252K | Jul 16 |
| Q4 2024 · Feb 29derived | $2.3M | — | 43.1% | $246K | $99K | — | 0.01 | −$87K | −$1K | −$86K | May 29 |
| Q3 2024 · Nov 30 | $2M | — | 43.1% | $258K | −$492K | — | -0.04 | $382K | — | — | Jan 14 |
| Q2 2024 · Aug 31 | $351K | — | 82.6% | $56K | −$33K | — | 0.00 | −$7K | — | — | Oct 15 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Feb 28 | $9.7M | 52.7% | $1.1M | $795K | 8.2% | 0.07 | $907K | $1K | $905K | — | — |
| FY2025 · to Feb 28 | $9.1M | 52.9% | $3.2M | $2.2M | 23.7% | 0.18 | $878K | $89K | $789K | — | — |
| FY2024 · to Feb 29 | $5M | 48.7% | $601K | −$405K | -8.1% | -0.03 | $14K | −$2K | $16K | — | — |
| FY2023 · to Feb 28 | $1M | 58.2% | −$239K | −$353K | -35.3% | -0.03 | −$491K | $55K | −$546K | — | — |
Every number comes from Medinotec Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.